Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C1864663 (
HCC
)
2,985
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We conducted a case-control study in China to clarify the association between
XRCC1
-Arg399Gln polymorphism and
HCC
risk. A total of 150 cases and 158 controls were selected from the the Affiliated Hospital of Qingdao University from May 2008 to May 2010.
XRCC1
-Arg399Gln polymorphism was based upon duplex polymerase-chain-reaction with the confronting-two-pair primer (PCR-CTPP) method. All analyses were performed using the STATA statistical package. A significantly increased risk was associated with the Arg/Gln genotype (adjusted OR 1.78, 95%CI=1.13-2.79) compared with genotype Arg/Arg. In contrast, the Gln/Gln genotype had non-significant increased risk of
HCC
with adjusted OR (95%CI) of 1.69 (0.93-2.66). A significant association was found between positive HBsAg and Arg/Gln, with an OR of 3.43 (95% CI=1.45-8.13). Patients carrying Gln/Gln genotypes showed significantly lower median survival than Arg/Arg genotypes (HR=1.38, 95% CI=1.04-1.84). Further Kaplan-Meier analysis showed decreased median survival in Arg/Gln+Gln/Gln genotype carriers in comparison to Arg/Arg carriers (HR=1.33, 95% CI=1.02-1.76). In conclusion, we observed that
XRCC1
-Arg399Cln polymorphism is associated with susceptibility to
HCC
, and
XRCC1
Gln allele genotype showed significant prognostic associations.
...
PMID:Evaluation of DNA repair gene XRCC1 polymorphism in prediction and prognosis of hepatocellular carcinoma risk. 2250 66
Background and aim:
DNA repair represents a protective mechanism against cell injury and cancer. 8-hydroxy-deoxyguanosine (8-OHdG) is the main ROS-induced DNA mutation. The current study aimed to evaluate urinary 8-OHdG levels in patients with chronic hepatitis C virus (HCV) and its related hepatocellular (
HCC
) and correlate its level to
XRCC1
rs25487 G/A and OGG1 rs1052133 C/G gene polymorphisms.
Materials and methods:
Urinary 8-OHdG assays were performed using HPLC technique, and
XRCC1
rs25487 G/A and OGG1 rs1052133 C/G gene polymorphisms were analyzed by PCR using confronting two-pair primer method (PCR-CTPP) in 200 subjects allocated into 50 chronic HCV patients, 50 HCV-related
HCC
patients, and 100 controls.
Results:
There were significantly increased urinary 8-OHdG levels in HCV-related
HCC
and chronic HCV patients when compared with the controls (
P
<0.05 for all). Urinary 8-OHdG was associated with the tumor spread. Regarding,
XRCC1
(Arg399Gln), AA (Gln/Gln) genotype and A-allele were more frequent in
HCC
and chronic HCV patients than in the controls (
P
<0.05). ORs (95%CI) using the dominant and the recessive genetic models were; 2.1 (1.1-4.1),
P
=0.032 and 1.9 (1-3.6),
P
=0.043 respectively. For OGG1 (Ser326Cys), GG (Cys/Cys) genotype and G-allele were increased significantly in chronic HCV and
HCC
patients compared to the controls (
P
<0.05). ORs (95%CI) under the dominant and the recessive genetic models were; 2.1 (1.1-4.1),
P
=0.032 and 1.9 (1-3.8),
P
=0.049 respectively. Additionally,
XRCC1
(AA) and OGG1 (GG) genotypes had significantly increased urinary 8-OHdG levels among patients (
P
<0.05).
Conclusions:
XRCC1
(AA) and OGG1 (GG) could be considered as possible genotypic risk factors for HCV- related
HCC
development which were associated with significantly high urinary 8-hydroxy-deoxyguanosine levels, thus urinary 8-OHdG could be considered as non-invasive marker in follow-up chronic HCV progression into
HCC
.
...
PMID:Urinary 8-hydroxydeoxyguanosine in relation to XRCC1 rs25487 G/A (Arg399Gln) and OGG1 rs1052133 C/G (Ser326Cys) DNA repair genes polymorphisms in patients with chronic hepatitis C and related hepatocellular carcinoma. 3135 43